Markets

An ETF to Capture Genomic Sequencing Innovation

ETF investors interested in the growth opportunities found in the biotechnology segment can look to initiatives in the health care segment, such as the developments in CRISPR genome-editing. On the recent webcast (available On Demand for CE Credit), As Genome-Editing Evolves, So Do The Investment Opportunities, Brett Winton, Director of Research at ARK Invest, highlighted [...] Read more on ETFtrends.com.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article was provided by our partner Tom Lydon of etftrends.com.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Other Topics

ETFs